Inga Buchmann

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

Inga Buchmann, Marcus Henze, Swantje Engelbrecht et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 506 citations

Neuroendocrine Tumours, Medicine, Neuroendocrine Disorder +11

Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

Markus Bangerter, Florian Moog, Inga Buchmann et al. · Annals of Oncology · 1998 · 246 citations · Full text

Positron Emission Tomography, Engineering, Oncologic Imaging +10

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma

Inga Buchmann, Michaël Reinhardt, Klaus Elsner et al. · Cancer · 2001 · 237 citations

PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma

Ingo Janssen, Clara C. Chen, Corina Millo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 176 citations · Full text

Positron Emission Tomography, Medical Imaging, Medicine +8

⁶⁸Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI

Ingo Janssen, Clara C. Chen, David Taïeb et al. · Journal of Nuclear Medicine · 2015 · 174 citations · Full text